NOT KNOWN FACTUAL STATEMENTS ABOUT HEMGENIX

Amount of qualified individuals: CDEC talked about the uncertainty in the amount of sufferers with moderately serious to serious hemophilia B in Canada qualified for etranacogene dezaparvovec. Clinical specialists consulted by CADTH indicated that some patients that are categorized as possessing mild or average disorder could possibly have a critic